循環器ジャーナル70巻3号

2022年07月発行

特集 進化するカテーテルインターベンション—適応の広がりとデバイスの革新 Ⅵ章　腎動脈・四肢動脈インターベンション

腎動脈・四肢動脈インターベンション

著者： 河原田修身¹

所属機関： ¹かわらだ心臓足血管クリニック

ページ範囲：P.489 - P.498

Point
・腎動脈狭窄症の血行再建は，粥状硬化性に対してステント留置，線維筋性異形成症に対してバルーン形成術が第一選択である．
・腎デナベーションは，降圧療法としての有効性がいまだ検討中である．
・動脈硬化性末梢動脈疾患に対する血管内治療の成績は向上し，適応は拡大している．

参考文献

1）Kawarada O, Yasuda S, Noguchi T, et al : Renovascular heart failure : heart failure in patients with atherosclerotic renal artery disease. Cardiovasc Interv Ther 31 : 171-182, 2016

2）Kawarada O, Kume T, Zen K, et al : Cardiac function response to stenting in atherosclerotic renal artery disease with and without heart failure : results from the Carmel study. ESC Heart Fail 6 : 319-327, 2019

3）Gornik HL, Persu A, Adlam D, et al : First international consensus on the diagnosis and management of fibromuscular dysplasia. J Hypertens 37 : 229-252, 2019

4）Aboyans V, Ricco JB, Bartelink MEL, et al ; ESC Scientific Document Group : 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery（ESVS） : Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by : the European Stroke Organization（ESO）. The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology（ESC）and of the European Society for Vascular Surgery（ESVS）. Eur Heart J 39 : 763-816, 2018

5）Kawarada O, Yokoi Y, Sakamoto S, et al : Impact of aortorenal morphology on renal artery stent procedures : significance of aortic tortuosity and renal artery derivation. J Endovasc Ther 21 : 140-147, 2014

6）Parikh SA, Shishehbor MH, Gray BH, et al : SCAI expert consensus statement for renal artery stenting appropriate use. Catheter Cardiovasc Interv 84 : 1163-1171, 2014

7）Bhatt DL, Kandzari DE, O'Neill WW, et al : A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370 : 1393-1401, 2014

8）Kandzari DE, Böhm M, Mahfoud F, et al : Effect of renal denervation on blood pressure in the presence of antihypertensive drugs : 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomized trial. Lancet 391 : 2346-2355, 2018

9）Townsend RR, Mahfoud F, Kandzari DE, et al : Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications（SPYRAL HTN-OFF MED） : a randomised, sham-controlled, proof-of-concept trial. Lancet 390 : 2160-2170, 2017

10）Azizi M, Schmieder RE, Mahfoud F, et al : Endovascular ultrasound renal denervation to treat hypertension（RADIANCE-HTN SOLO） : a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet 391 : 2335-2345, 2018

11）Kario K, Yokoi Y, Okamura K, et al : Catheter-based ultrasound renal denervation in patients with resistant hypertension : the randomized, controlled REQUIRE trial. Hypertens Res 45 : 221-231, 2022

12）Kawarada O, Zen K, Hozawa K, et al : Contemporary critical limb ischemia : Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care. Cardiovasc Interv Ther 33 : 297-312, 2018

13）Kawarada O, Sakamoto S, Harada K, et al : Contemporary crossing techniques for infrapopliteal chronic total occlusions. J Endovasc Ther 21 : 266-280, 2014

14）Kawarada O, Noguchi T, Yasuda S : Longitudinal Cracking with a Guidewire Tail for Extremely Calcified Lesions in Infrainguinal Arteries : PICKING Technique. Cardiovasc Intervent Radiol 41 : 313-316, 2018

15）Kato T, Zen K, Kawarada O, et al : Clinical outcomes of endovascular treatment for chronic aortic occlusion : a retrospective multicentre registry : EVT for chronic aortic occlusion. AsiaIntervention 5 : 121-127, 2019

16）Katsanos K, Spiliopoulos S, Kitrou P, et al : Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg : a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 7 : e011245, 2018

17）Nordanstig J, James S, Andersson M, et al : Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease. N Engl J Med 383 : 2538-2546, 2020

18）Kawarada O, Yasuda S, Nishimura K, et al : Effect of single tibial artery revascularization on microcirculation in the setting of critical limb ischemia. Circ Cardiovasc Interv 7 : 684-691, 2014

19）Kawarada O, Fujihara M, Higashimori A, et al : Predictors of adverse clinical outcomes after successful infrapopliteal intervention. Catheter Cardiovasc Interv 80 : 861-871, 2012

20）Kawarada O, Yokoi Y. Dorsalis pedis artery stenting for limb salvage. Catheter Cardiovasc Interv 71 : 976-982, 2008

21）Kawarada O, Yokoi Y, Higashimori A, et al : Stent-assisted below-the-ankle angioplasty for limb salvage. J Endovasc Ther 18 : 32-42, 2011

22）Yamamoto Y, Kawarada O, Ando H, et al : Effects of high-speed rotational atherectomy in peripheral artery disease patients with calcified lesions : a retrospective multicenter registry. Cardiovasc Interv Ther 35 : 393-397, 2020

23）Yagyu T, Ito S, Kawarada O, et al : Rationale and Design of a Prospective, Multicenter, Single-Arm Clinical Trial to Investigate the Safety and Effectiveness of Rotablator Atherectomy System as an Adjunctive Device for Endovascular Treatment of Occlusive Atherosclerotic Lesions in Below-the-Knee Arteries With Critical Limb Ischemia （RESCUE-BTK）. Circ Rep 2 : 449-454, 2020

24）Kawarada O, Kume T, Ayabe S, et al : Endovascular therapy outcomes and intravascular ultrasound findings in thromboangiitis obliterans（Buerger's disease）. J Endovasc Ther 24 : 504-515, 2017